Health Care · Health Care Equipment
ResMed Inc. RMD
$199.03-3.73 (-1.84%)delayed quote · as of 2026-07-17 19:17 UTC
Market cap
$28.9B
Previous close
$202.76
Volume
616K
52-week range
$180.27 – $293.81
Verdictconfidence 100% · high
Attractively priced, with the trend still against it.
4 of 5 dimensions score well; momentum flashes caution.
Value1004/4 checks
Growth1004/4 checks
Quality1003/3 checks
Health1003/3 checks
Momentum00/5 checks
Fair-value estimate $437.66 per share (2-stage FCF · individual beta · 10Y Rf 4.5%) — the price sits 55% below it.
Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.
Key ratioslatest filing FY 2025
Value
P/E TTM
19.2
P/E NTM
16.9
EV/EBITDA
13.5
PEG
1.17
Growth
Revenue 3y
+12.9%/yr
Revenue YoY
+9.8%
Expected EPS
+13.4%
Quality
ROE
23.5%
Quality checks
bank measures
Health
ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-17 19:17 UTC · fundamentals FY 2025 · SEC EDGAR
Continue with RMD in ALAN
Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.
For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.